IP Library Granted Patent US 7,410,765
Granted Patent B2
US 7,410,765 · App. 11/281,644 · Granted Aug 12, 2008

System for protease mediated protein expression

Assignee: The Regents of the University of California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,410,765
App. No.
11/281,644
Granted
Aug 12, 2008
Kind
B2
Abstract

The present invention provides methods and materials that can be used to detect, examine and exploit protease mediated protein expression. An illustrative embodiment of the invention is a polynucleotide encoding a polypeptide having a plurality of operatively linked elements comprising a polypeptide degradation signal that functions as a proteosome substrate; a polypeptide of interest having an observable activity; and a linker disposed between the polypeptide degradation signal and the polypeptide of interest. The linker comprises a protease recognition motif that is capable of being specifically recognized and cleaved by a protease. The activity of the polypeptide of interest is observed when the motif is specifically recognized and cleaved by the protease; and the activity of the polypeptide of interest is decreased or not observed when the motif is not specifically recognized and cleaved by the protease.

Claims (13)

1. A polynucleotide encoding a protease-regulated polypeptide comprising the following operatively linked elements:

(a) a nucleic acid sequence encoding a protein degradation signal;

(b) a nucleic acid sequence encoding a polypeptide of interest; and

(c) a nucleic acid sequence encoding a linker set forth as SEQ ID NO:1 disposed between (a) and (b), wherein the linker comprises a protease recognition motif that is cleaved by a protease;

wherein, in the presence of the protease, cleavage of the linker protects the polypeptide of interest from proteasomal degradation; and, in the absence of the protease, activity of the polypeptide of interest is decreased.

2. A first vector comprising the polynucleotide of claim 1 .

3. A cell comprising the first vector of claim 2 .

4. The polynucleotide of claim 1 , wherein the protein degradation signal is a ubiquitin degradation signal.

5. The polynucleotide of claim 1 , wherein the polypeptide of interest is a reporter protein whose expression can be detected.

6. The polynucleotide of claim 1 , wherein the polypeptide of interest is a therapeutically active polypeptide.

7. The first vector of claim 2 , further comprising a promoter and/or an enhancer that modulates the expression of the protease-regulated polypeptide.

8. The cell of claim 3 , wherein the polypeptide of interest is a first reporter protein, and the cell further comprises a second vector that encodes a second reporter protein whose expression is modulated by a tissue specific promoter or a tissue specific enhancer.

9. A kit comprising the polynucleotide of claim 1 and a suitable container.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2005
From: LACOSTE, ARNAUD; EVANS, CHRISTOPHER J.
To: REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE
Reel/Frame 017259/0813 →
Continuity (2)
Provisional Application 6062869400 · Nov 17, 2004
Related Publication 20060105953A1 · May 18, 2006